9/24/2009 – Cambridge, Mass. Peptimmune, Inc. announced today that it has formed a research and development collaboration with the Walter Reed Army Institute of…
8/25/2009 – CAMBRIDGE, Mass. - Peptimmune announced today the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics…